RASSF1 and ductal breast carcinoma in situ: In all, 30% of DCIS without invasive breast cancer also underwent RASSF1A promoter hypermethylation, suggesting that inactivation of RASSF1A by CpG island methylation is an early event in breast tumorigenesis.